U.S. Other Utilities Stock News

In late February 2026, RLI Corp. completed a US$300 million fixed-rate senior unsecured bond offering of 5.375% Notes due June 1, 2036, following a new debt shelf registration and alongside a board decision to maintain its quarterly dividend at US$0.16 per share, extending a 50-year dividend increase streak. A recent AM Best upgrade of RLI Group’s financial strength rating to A++, coupled with an equity-backed partnership with AI-focused insurer Kettle to launch a new multi-peril commercial...

EyePoint, Inc. recently appointed Michael Campbell as Chief Commercial Officer, giving him responsibility for commercial strategy and launch preparation for DURAVYU, its Phase 3 retinal disease candidate. The hire brings in a leader who helped shape the commercial playbooks behind Lucentis, Xiidra, Beovu and Tyrvaya, directly relevant to DURAVYU’s target markets. We’ll now examine how adding a veteran ophthalmology launch executive to oversee DURAVYU’s commercialization may influence...

On February 25, 2026, Xylem Inc. (NYSE: XYL) authorized a new US$1.50 billion share repurchase program with no expiration date, alongside an 8% increase in its quarterly dividend. The combination of a sizable buyback, higher dividend, and recent record profitability underlines management’s confidence in Xylem’s cash generation and balance sheet strength. We’ll now examine how Xylem’s sizeable new buyback authorization could reshape its investment narrative around capital allocation and...

Event driven snapshot of BioMarin Pharmaceutical BioMarin Pharmaceutical (BMRN) is back on investor radars after recent share price moves, with the stock up about 8% over the past month and roughly 10% over the past 3 months. See our latest analysis for BioMarin Pharmaceutical. While the recent 30 day share price return of about 8% and 90 day gain of roughly 10% suggest momentum is building again, the 1 year total shareholder return of about a 13% decline and a roughly 39% decline over three...

Emerson Electric (EMR) is back on investors’ radar after its Q1 2026 earnings report and a higher full year EPS forecast, with management pointing to electrification and nearshoring as key demand drivers. See our latest analysis for Emerson Electric. The Q1 earnings beat and raised EPS guidance arrived after a strong run, with a 90 day share price return of 14.26% and a 1 year total shareholder return of 26.02%, suggesting momentum has been building over both shorter and longer periods. If...

DT Midstream (DTM) is back in focus after reporting full year 2025 results, with sales of US$1,243 million and net income of US$441 million. The company also announced a 7% quarterly dividend increase to US$0.88 per share. See our latest analysis for DT Midstream. DT Midstream’s recent earnings and dividend update come after a strong run in the shares, with the latest share price at US$138.84 and a 30 day share price return of 10.66%. The 1 year total shareholder return sits at 49.01% and the...

Why Bob's Discount Furniture stock is drawing attention now Bob's Discount Furniture (BOBS) is on some investors' radar after its recent share price moves, with the stock flat over the past day but lower over the past week. At a last close of US$21.24, the retailer of home furnishings, mattresses, and accessories is showing a year to date return of about 24.8%, which has prompted closer scrutiny of its current valuation. See our latest analysis for Bob's Discount Furniture. The recent 7 day...

Septerna, Inc. recently reported very large revenue growth, underpinned by progress in its GPCR-based oral small molecule pipeline for diseases including hypoparathyroidism, chronic spontaneous urticaria, and Graves’ disease. This surge in activity has coincided with strong analyst enthusiasm for Septerna’s advancing clinical programs, underscoring how pipeline momentum is reshaping its business profile within biotechnology. Next, we’ll examine how this very large revenue growth and...

ATRenew (RERE) is back in focus after recent coverage highlighted revenue growth of 22% and earnings expanding more than fourfold, as investors look ahead to its March 11, 2026 unaudited 2025 results release. See our latest analysis for ATRenew. That backdrop helps explain why investor sentiment has shifted, with a 90 day share price return of 26.42% and a 1 year total shareholder return of 104.59%. This comes even though the latest 1 day move was a 3.34% share price decline to US$5.79,...

VSE (VSEC) has just reported quarterly results that came in ahead of analyst expectations, with higher operating margins, record aviation revenue, and a 2026 growth outlook that factors in recent acquisitions. See our latest analysis for VSE. Those results come after a strong run in the shares, with the latest price at $227.07, a 90 day share price return of 30.31% and a 1 year total shareholder return of 92.15%. This points to strengthening momentum as investors reassess growth prospects and...

In February 2026, Trinity Capital Inc. reported its fourth-quarter and full-year 2025 results, with revenue rising to US$83.24 million for the quarter and US$293.65 million for the year, alongside higher annual net income but lower earnings per share versus 2024. The company paired these record operating figures with a shift to monthly dividends, an intensified focus on AI infrastructure financing, and a US$50 million growth capital commitment to UK-based Dwelly, signaling an emphasis on...

Omnicell has recently accelerated its shift from hardware-focused sales toward software and services, including acquiring ANiGENT in October 2025 to broaden its drug diversion detection capabilities and recurring revenue base. This pivot toward subscription-like revenue streams is prompting investors to reassess Omnicell less as a traditional equipment maker and more as a healthcare IT provider, with different expectations for growth, risk and valuation. Next, we’ll examine how Omnicell’s...

In Q4 2025, Harbor Capital Advisors' Mid Cap Value Fund disclosed that it had initiated a new position in EnerSys, citing improving operating margins, sales growth, strong cash flow, ongoing share buybacks, and regular dividend payments as key reasons for the investment. The fund also ranked EnerSys in the top 5% of its evaluation universe, highlighting how the company’s combination of operating momentum and capital returns screens well against a broad mid-cap peer group. Next, we’ll examine...

Arcus Biosciences stock: event driven overview Arcus Biosciences (RCUS) has caught investor attention after recent trading action, with the stock now sitting around $20.37. That move comes against a mixed return profile across the past month and past 3 months. See our latest analysis for Arcus Biosciences. The latest move puts Arcus Biosciences at US$20.37, with the 1 day share price return of 4.25% and 7 day share price return of 7.27% sitting against a weaker 90 day share price return of a...

Recent commentary around MGM Resorts International (MGM) has focused on its aggressive share repurchases, the expanding BetMGM digital gaming footprint, and a series of catalysts that include asset sales, the Las Vegas recovery, and the planned Osaka integrated resort. See our latest analysis for MGM Resorts International. At a share price of $36.86, MGM’s recent 30 day share price return of 9.90% contrasts with a 1 year total shareholder return of 6.04% and a 3 year total shareholder loss of...

Valley National Bancorp (VLY) shares dropped 6.2% as hotter inflation data and growing credit risk worries pressured regional lenders, even though the bank confirmed regular dividends and a new share repurchase authorization. See our latest analysis for Valley National Bancorp. Despite the latest 5.7% one day share price decline to US$12.61, Valley National Bancorp’s 90 day share price return of 9.8% and 1 year total shareholder return of 34.0% suggest momentum has generally been positive...

Arcosa (ACA) is back on investors’ radar after a recent share pullback over the past week and month, drawing attention to how its infrastructure focused business and current valuation metrics stack up today. See our latest analysis for Arcosa. The sharp 1 day share price decline of 15.7% and 7 day share price return of 14.9% sit against a 1 year total shareholder return of 28.42% and 5 year total shareholder return of 84.39%. This suggests recent momentum has cooled after a strong multi year...

Why Marriott Vacations Worldwide (VAC) Is Drawing Fresh Attention Marriott Vacations Worldwide (VAC) has been catching investors’ eyes after recent share moves, with the stock showing a mix of shorter term gains and longer term weakness that raises questions about valuation and business momentum. See our latest analysis for Marriott Vacations Worldwide. The recent 7 day share price return of 10.37% and 30 day share price return of 19.70% contrast with a 1 year total shareholder return decline...

Franklin Resources recently reported quarterly earnings per share that came in above analyst consensus, while Franklin Templeton Canada adjusted risk ratings on selected funds following an Ontario Securities Commission review that did not alter their mandates or management. Alongside this earnings surprise, Franklin Resources is highlighting its presence at the THRIVE Energy Conference in Houston, where portfolio manager Fred Fromm is presenting, underscoring the firm’s efforts to engage...

In February 2026, Ladder Capital Corp. announced it had secured US$675 million in new unsecured capital commitments, expanding its unsecured revolving credit facility to US$1.25 billion and adding a US$275 million unsecured delayed draw term loan priced at 140 basis points over SOFR. This package of same-day liquidity at 125 basis points over SOFR and long-dated funding to 2030 materially strengthens Ladder’s funding flexibility and duration profile. Next, we’ll examine how this expanded...

Sable Offshore Corp. reported a full-year net loss of US$410.16 million for 2025, an improvement from the prior year’s US$629.07 million loss, alongside the restart of production at its Santa Ynez Unit after completing pipeline repairs and hydrotests. The company also secured key regulatory support, including PHMSA oversight and an emergency special permit, and advanced its offshore storage and treating vessel strategy to access both domestic and global petroleum markets. We’ll now look at...

In its latest quarterly update, First Financial Bancorp reported revenue up 12.1% year on year, alongside beats on analysts’ revenue, tangible book value per share, and earnings per share estimates. This outperformance came despite the bank’s historically modest revenue and net interest income growth, highlighting a recent improvement relative to earlier trends. With these earnings and tangible book value surprises now on the table, we’ll examine how they reshape First Financial Bancorp’s...

Horace Mann Educators (HMN) has launched the Horace Mann Club, a complimentary program that broadens its educator support through professional development, fitness and wellness partnerships, financial wellness tools, and classroom resources. See our latest analysis for Horace Mann Educators. At a share price of $43.51, Horace Mann Educators has seen a 7 day share price return of 0.90%, alongside a year to date share price decline of 3.70%. Its 1 year total shareholder return of 6.10% and 3...

Primerica (PRI) has been back in focus after its latest 10-K highlighted growth tied to commissions, fees, and net premiums, along with higher dividends, ongoing share repurchases, and reaffirmed strong credit ratings from AM Best. See our latest analysis for Primerica. Despite stronger financial disclosures and affirmed credit ratings, Primerica’s recent share price momentum has cooled, with a 30-day share price return of a 3.57% decline and a 1-year total shareholder return of an 11.09%...